Sleep.ai’s new release turns any smartphone into a passive sleep sensor, aiming to bring continuous, privacy-preserving sleep measurement to the majority of adults who do not use wearables.
Read More
Positive trial results position the next-generation pitolisant formulation for a New Drug Application in early 2026.
Read More
It will launch in early 2026 in a limited US beta version.
Read More
The company is phasing in a rebrand that emphasizes continuity with its legacy while positioning its portfolio for global partnerships and potential deals.
Read More
New findings serve to update a broader hypothesis that has been in development at WSU for years—proposing that sleep arises from communication between the body’s sleep regulatory systems and the multitude of microbes living inside us.
Read More